Edgewise Roic vs Capex To Depreciation Analysis

EWTX Stock

USD 16.40 0.94 6.08%

Edgewise Therapeutics financial indicator trend analysis is much more than just examining Edgewise Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Edgewise Therapeutics is a good investment. Please check the relationship between Edgewise Therapeutics Roic and its Capex To Depreciation accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edgewise Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Edgewise Stock please use our How to Invest in Edgewise Therapeutics guide.

Roic vs Capex To Depreciation

Roic vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Edgewise Therapeutics Roic account and Capex To Depreciation. At this time, the significance of the direction appears to have strong relationship.

The correlation between Edgewise Therapeutics' Roic and Capex To Depreciation is 0.66. Overlapping area represents the amount of variation of Roic that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Edgewise Therapeutics, assuming nothing else is changed. The correlation between historical values of Edgewise Therapeutics' Roic and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Roic of Edgewise Therapeutics are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Roic i.e., Edgewise Therapeutics' Roic and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

0.66

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Roic

Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Most indicators from Edgewise Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Edgewise Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edgewise Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Edgewise Stock please use our How to Invest in Edgewise Therapeutics guide.At this time, Edgewise Therapeutics' Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 2.3 B in 2025, whereas Issuance Of Capital Stock is likely to drop slightly above 128.1 M in 2025.

	2022	2023	2024	2025 (projected)
Interest Income	4.0M	14.2M	25.0M	26.3M
Net Interest Income	4.0M	14.2M	25.0M	26.3M

Interest Income Net Interest Income

Edgewise Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Net Working Capital	Property Plant Equipment	Non Currrent Assets Other	Other Assets	Deferred Long Term Liab
Total Assets		-0.44	0.98	0.99	0.98	0.95	0.89	-0.64	-0.88	0.98	0.57	0.93	1.0	0.79	-0.45	0.9	0.93	-0.24	0.98	0.86	1.0	1.0	0.89	0.28	-0.96	-0.96
Short Long Term Debt Total	-0.44		-0.46	-0.48	-0.6	-0.61	-0.5	0.52	0.48	-0.48	-0.21	-0.51	-0.44	-0.39	1.0	-0.56	-0.56	0.96	-0.6	-0.5	-0.44	-0.44	-0.52	-0.22	0.59	0.59
Other Current Liab	0.98	-0.46		0.99	0.97	0.93	0.92	-0.51	-0.92	0.93	0.41	0.91	0.98	0.88	-0.47	0.84	0.93	-0.26	0.97	0.9	0.98	0.98	0.9	0.12	-0.94	-0.93
Total Current Liabilities	0.99	-0.48	0.99		0.98	0.95	0.93	-0.59	-0.9	0.97	0.49	0.94	0.99	0.84	-0.49	0.88	0.94	-0.27	0.98	0.89	0.99	0.99	0.92	0.22	-0.96	-0.95
Total Stockholder Equity	0.98	-0.6	0.97	0.98		0.97	0.89	-0.69	-0.86	0.97	0.56	0.93	0.98	0.78	-0.61	0.92	0.93	-0.42	1.0	0.85	0.98	0.98	0.88	0.32	-0.96	-0.98
Net Tangible Assets	0.95	-0.61	0.93	0.95	0.97		0.87	-0.66	-0.91	0.95	0.52	0.92	0.95	0.73	-0.62	0.92	0.98	-0.4	0.97	0.9	0.95	0.95	0.93	0.26	-0.99	-0.96
Property Plant And Equipment Net	0.89	-0.5	0.92	0.93	0.89	0.87		-0.48	-0.85	0.87	0.36	0.96	0.88	0.77	-0.5	0.87	0.86	-0.31	0.89	0.92	0.88	0.88	0.94	0.12	-0.92	-0.85
Net Debt	-0.64	0.52	-0.51	-0.59	-0.69	-0.66	-0.48		0.3	-0.76	-0.95	-0.68	-0.65	-0.11	0.53	-0.82	-0.49	0.45	-0.69	-0.31	-0.64	-0.65	-0.45	-0.88	0.65	0.77
Retained Earnings	-0.88	0.48	-0.92	-0.9	-0.86	-0.91	-0.85	0.3		-0.82	-0.16	-0.81	-0.88	-0.9	0.48	-0.72	-0.98	0.24	-0.86	-0.97	-0.88	-0.88	-0.95	0.12	0.91	0.8
Accounts Payable	0.98	-0.48	0.93	0.97	0.97	0.95	0.87	-0.76	-0.82		0.68	0.95	0.98	0.69	-0.49	0.94	0.9	-0.29	0.97	0.81	0.98	0.98	0.88	0.45	-0.96	-0.96
Cash	0.57	-0.21	0.41	0.49	0.56	0.52	0.36	-0.95	-0.16	0.68		0.59	0.57	-0.02	-0.23	0.73	0.35	-0.16	0.56	0.17	0.56	0.57	0.32	0.92	-0.52	-0.65
Non Current Assets Total	0.93	-0.51	0.91	0.94	0.93	0.92	0.96	-0.68	-0.81	0.95	0.59		0.92	0.66	-0.51	0.96	0.87	-0.32	0.93	0.87	0.92	0.92	0.93	0.36	-0.95	-0.92
Cash And Short Term Investments	1.0	-0.44	0.98	0.99	0.98	0.95	0.88	-0.65	-0.88	0.98	0.57	0.92		0.79	-0.45	0.89	0.93	-0.23	0.98	0.85	1.0	1.0	0.88	0.29	-0.95	-0.96
Common Stock Shares Outstanding	0.79	-0.39	0.88	0.84	0.78	0.73	0.77	-0.11	-0.9	0.69	-0.02	0.66	0.79		-0.4	0.51	0.82	-0.21	0.78	0.84	0.79	0.78	0.8	-0.25	-0.73	-0.67
Non Current Liabilities Total	-0.45	1.0	-0.47	-0.49	-0.61	-0.62	-0.5	0.53	0.48	-0.49	-0.23	-0.51	-0.45	-0.4		-0.57	-0.57	0.96	-0.61	-0.5	-0.45	-0.45	-0.52	-0.23	0.59	0.61
Other Current Assets	0.9	-0.56	0.84	0.88	0.92	0.92	0.87	-0.82	-0.72	0.94	0.73	0.96	0.89	0.51	-0.57		0.83	-0.39	0.92	0.77	0.89	0.89	0.84	0.51	-0.94	-0.95
Other Stockholder Equity	0.93	-0.56	0.93	0.94	0.93	0.98	0.86	-0.49	-0.98	0.9	0.35	0.87	0.93	0.82	-0.57	0.83		-0.33	0.93	0.95	0.93	0.93	0.95	0.08	-0.97	-0.89
Total Liab	-0.24	0.96	-0.26	-0.27	-0.42	-0.4	-0.31	0.45	0.24	-0.29	-0.16	-0.32	-0.23	-0.21	0.96	-0.39	-0.33		-0.42	-0.27	-0.23	-0.23	-0.29	-0.24	0.37	0.42
Net Invested Capital	0.98	-0.6	0.97	0.98	1.0	0.97	0.89	-0.69	-0.86	0.97	0.56	0.93	0.98	0.78	-0.61	0.92	0.93	-0.42		0.85	0.98	0.98	0.88	0.32	-0.96	-0.98
Property Plant And Equipment Gross	0.86	-0.5	0.9	0.89	0.85	0.9	0.92	-0.31	-0.97	0.81	0.17	0.87	0.85	0.84	-0.5	0.77	0.95	-0.27	0.85		0.85	0.85	0.98	-0.1	-0.92	-0.8
Total Current Assets	1.0	-0.44	0.98	0.99	0.98	0.95	0.88	-0.64	-0.88	0.98	0.56	0.92	1.0	0.79	-0.45	0.89	0.93	-0.23	0.98	0.85		1.0	0.88	0.28	-0.96	-0.96
Net Working Capital	1.0	-0.44	0.98	0.99	0.98	0.95	0.88	-0.65	-0.88	0.98	0.57	0.92	1.0	0.78	-0.45	0.89	0.93	-0.23	0.98	0.85	1.0		0.88	0.29	-0.95	-0.96
Property Plant Equipment	0.89	-0.52	0.9	0.92	0.88	0.93	0.94	-0.45	-0.95	0.88	0.32	0.93	0.88	0.8	-0.52	0.84	0.95	-0.29	0.88	0.98	0.88	0.88		0.08	-0.95	-0.83
Non Currrent Assets Other	0.28	-0.22	0.12	0.22	0.32	0.26	0.12	-0.88	0.12	0.45	0.92	0.36	0.29	-0.25	-0.23	0.51	0.08	-0.24	0.32	-0.1	0.28	0.29	0.08		-0.26	-0.4
Other Assets	-0.96	0.59	-0.94	-0.96	-0.96	-0.99	-0.92	0.65	0.91	-0.96	-0.52	-0.95	-0.95	-0.73	0.59	-0.94	-0.97	0.37	-0.96	-0.92	-0.96	-0.95	-0.95	-0.26		0.96
Deferred Long Term Liab	-0.96	0.59	-0.93	-0.95	-0.98	-0.96	-0.85	0.77	0.8	-0.96	-0.65	-0.92	-0.96	-0.67	0.61	-0.95	-0.89	0.42	-0.98	-0.8	-0.96	-0.96	-0.83	-0.4	0.96

Click cells to compare fundamentals

Edgewise Therapeutics Account Relationship Matchups

Edgewise Therapeutics fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	131.1M	285.2M	367.1M	340.0M	486.8M	299.7M
Other Current Liab	2.8M	6.7M	9.3M	11.8M	17.3M	8.8M
Total Current Liabilities	4.3M	10.5M	16.6M	16.8M	23.9M	13.4M
Total Stockholder Equity	(33.4M)	274.4M	346.7M	318.8M	459.2M	247.3M
Property Plant And Equipment Net	516K	912K	9.9M	12.7M	11.1M	6.5M
Net Debt	55.3M	(280.8M)	(347.5M)	(80.7M)	(36.9M)	(38.8M)
Retained Earnings	(34.1M)	(77.0M)	(144.6M)	(244.8M)	(378.6M)	(359.6M)
Accounts Payable	1.6M	3.8M	6.1M	4.0M	5.6M	4.0M
Cash	104.9M	280.8M	351.9M	86.1M	41.7M	39.6M
Non Current Assets Total	1.5M	4.4M	15.2M	13.0M	11.3M	8.4M
Cash And Short Term Investments	129.1M	280.8M	351.9M	318.4M	470.2M	288.6M
Short Term Investments	24.2M	265.2M	330.0M	232.3M	428.5M	234.7M
Liabilities And Stockholders Equity	131.1M	285.2M	367.1M	340.0M	486.8M	299.7M
Non Current Liabilities Total	160.2M	329K	3.8M	4.4M	3.7M	3.6M
Other Current Assets	551K	6.0M	10.1M	8.6M	5.3M	5.7M
Other Stockholder Equity	727K	351.9M	492.7M	563.5M	837.4M	879.2M
Total Liab	164.6M	10.9M	20.4M	21.2M	27.6M	38.1M
Net Invested Capital	(33.4M)	274.4M	346.7M	318.8M	459.2M	247.3M
Property Plant And Equipment Gross	516K	912K	8.5M	15.3M	15.8M	16.5M
Total Current Assets	129.6M	280.8M	351.9M	327.0M	475.5M	291.3M
Accumulated Other Comprehensive Income	(430K)	(514K)	(1.4M)	99K	420K	441K
Net Working Capital	125.3M	273.3M	340.4M	310.2M	451.6M	279.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

AMT	American Tower Corp
HLTOY	Hellenic Telecommunications Org
NFLX	Netflix

Additional Tools for Edgewise Stock Analysis

When running Edgewise Therapeutics' price analysis, check to measure Edgewise Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edgewise Therapeutics is operating at the current time. Most of Edgewise Therapeutics' value examination focuses on studying past and present price action to predict the probability of Edgewise Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edgewise Therapeutics' price. Additionally, you may evaluate how the addition of Edgewise Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Edgewise Roic vs Capex To Depreciation Analysis

Roic vs Capex To Depreciation

Roic vs Capex To Depreciation Correlation Analysis

Correlation Coefficient

Roic

Capex To Depreciation

Edgewise Therapeutics fundamental ratios Correlations

Edgewise Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Edgewise Therapeutics fundamental ratios Accounts

Also Currently Popular

Additional Tools for Edgewise Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments

Other Assets	- 0.99	Net Tangible Assets
Deferred Long Term Liab	- 0.98	Net Invested Capital
Other Stockholder Equity	- 0.98	Retained Earnings
Deferred Long Term Liab	- 0.98	Total Stockholder Equity
Other Assets	- 0.97	Other Stockholder Equity
Property Plant And Equipment Gross	- 0.97	Retained Earnings